About GF Life Science
GF Life Science is a publicly listed company based in Suwon (South Korea) founded in 2002. Cosmetics and related ingredients are developed for the beauty sector. The company has 80 employees. Its chief executive, as recorded, is Michael Kang. GF Life Science offers products and services including Skin Microbiome Research and Clinical Trials. Its focus areas include Cosmeceuticals. Its legal entity in India is μ£Όμνμ¬ μ§μνμ¨μλͺ κ³Όν (U99999MH1977PLC010754).
Company details
GF Life Science was established in 2002 in Suwon-si, South Korea. Operations are centered on the cosmetics industry, where ingredients and products for beauty applications are developed. The company is led by CEO Michael Kang. Focus is placed on research and formulation processes to support cosmetic manufacturing. Activities are conducted primarily in the South Korean market, with an online presence via gfcos.co.kr.
- Headquarters Suwon, South Korea
- Employees 80
- Stage Public
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website gfcos.co.kr
- Social Instagram
- Legal Name Gfc Life Science Co., Ltd.
- Annual Revenue$12.26 M (USD)5.42as on Dec 31, 2025
- Net Profit$384.59 K (USD)as on Dec 31, 2025
- EBITDA$1.45 M (USD)-36.07as on Dec 31, 2025
- Employee Count80
Associated legal entities of GF Life Science
GF Life Science operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | View details |
Products & Services of GF Life Science
GF Life Science offers a comprehensive portfolio of products and services, including Skin Microbiome Research and Clinical Trials.
Research on Skin Microbiome is conducted using metadata-based methods and strain libraries
Trials for safety and efficacy of cosmetic products are carried out by dermatologists
People of GF Life Science
1 people are tracked at GF Life Science (1 in leadership); the tracked headcount is 80.
| Name | Role | Group |
|---|---|---|
Michael Kang | CEO | Leadership |
Complete people profiles for GF Life Science
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of GF Life Science
GF Life Science is a publicly listed company on the KRX with ticker symbol 388610 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date30 Jun 2025
- Listed onKRX: 388610
- Listed entityGFC Life Science Co., Ltd.
- Exchange sectorHealth technology
- ISINKR7388610008
- Share price4,860.00 KRW (-2.8% on the day) · 2026-10-14
- Market capitalisation26,564,414,501.00 KRW
- Price to earnings23.9
- EPS (diluted, trailing year)203.76 KRW
- Volume (last session)30,130
Financials of GF Life Science
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 17.71B KRW | 555.4M KRW | 2.10B KRW |
| 2024 | 16.80B KRW | -5.95B KRW | 3.29B KRW |
| 2023 | 15.43B KRW | 2.10B KRW | 2.26B KRW |
| 2022 | 14.16B KRW | 327.3M KRW | 1.73B KRW |
| 2021 | 13.74B KRW | 1.62B KRW | 2.28B KRW |
Balance sheet, profit and loss, cash flow and ratios of , are on its company page.
Detailed financial statements for GF Life Science
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of GF Life Science
The website of GF Life Science (gfcos.co.kr) receives about 3.6K visits a month.
- Monthly visits3.6K
▼ 20.9% vs previous month
Websites whose visitors overlap most with GF Life Science. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
komabiotech.co.kr | komabiotech.co.kr | 100% | #1,931,229 | β |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Gf Life Science
Complete news archive for GF Life Science
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GF Life Science
GF Life Science was founded in 2002.
GF Life Science is headquartered in Suwon, South Korea. It is registered at Suwon, Gyeonggi, South Korea.
Michael Kang is the CEO of GF Life Science, as recorded in our data.
GF Life Science has 80 employees.
Annual revenue of GF Life Science is $12.26M as on Dec 31, 2025.
GF Life Science was established in 2002 in Suwon-si, South Korea. Operations are centered on the cosmetics industry, where ingredients and products for beauty applications are developed. The company is led by CEO Michael Kang. Focus is placed on research and formulation processes to support cosmetic manufacturing. Activities are conducted primarily in the South Korean market, with an online presence via gfcos.co.kr.
GF Life Science offers Skin Microbiome Research and Clinical Trials.
Yes, GF Life Science is publicly traded on KRX under the ticker symbol 388610.
GF Life Science operates through ,.